Pilot examines how an app could reduce substance abuse disorder relapse
MAP Health Management, which makes a remote monitoring and patient engagement platform focused on people with substance abuse disorder, has partnered with relapse reduction app WeConnect in a pilot to measure risk of relapse for people in MAP’s system. The WeConnect pilot will enroll 200 people who are currently using MAP post-acute engagement and care coordination services. Using data from the WeConnect app, MAP will algorithmically assess each person’s risk of relapse, with the ultimate goal of understanding which patient demographics could best be served by the app. This is the third pilot for MAP in recent months – they recently partnered with remote breathalyzer company Soberlink – and the company has big plans to expand its footprint in population health management for those dealing with substance abuse. As they get more data, MAP plans to expand its ecosystem of treatment providers, payers and digital tools to improve clinical and financial outcomes.
“We believe there is a large demographic out there who will be very responsive to engaging a mobile application as part of their recovery,” MAP Health CEO Jacob Levenson said in a statement. “Understanding who is at risk of relapse is essential to directing resources more efficiently and ultimately improving outcomes for those with Substance Use Disorder.”
VR outperforms 2D videos in pain reduction
Cedars Sinai has published the results of a study on the use of virtual reality to treat pain in acute inpatient settings. Compared with a basic two-dimensional video designed as a distraction for pain in patients in the hospital, the immersive, 3D experience of VR resulted in a more significant reduction of pain, the researchers say.
BMJ offers app to spur conversation between doctors, researchers
British medical journal and resource hub BMJ – noted for its early foray into online publishing in the mid 90s – is partnering with physician-facing app Figure 1 to bring their research database directly to the app and promote discussion immediately following the publication of new research. BMJ counts over a million doctors, nurses and medical students on the platform, and the publication wants them to use the app to discuss their work with target audiences.